The University of Naples Federico II is a public university in Naples, Italy. Founded in 1224, it is the oldest public non-sectarian university in the world, and is now organized into 26 departments.

During the past decade, University of Naples Federico II conducted 71 clinical trials. In the 10-year time frame, 71 clinical trials started and 8 clinical trials were completed, i.e. on average, 11.3% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 3 clinical trials were completed. i.e. 10% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Naples Federico II" #1 sponsor was "Federico II University" with 71 trials, followed by "University of Campania "Luigi Vanvitelli"" with 6 trials sponsored, "National Cancer Institute, Naples" with 4 trials sponsored, "Ipsen" with 3 trials sponsored and "Boston Scientific Corporation" with 3 trials sponsored. Other sponsors include 27 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Naples Federico II" #1 collaborator was "Azienda Sanitaria Locale Napoli 2 Nord" with 2 trials as a collaborator, "Federico II University" with 2 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator, "AdvicePharma Group" with 1 trials as a collaborator and "Amphia Hospital" with 1 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "University of Naples Federico II" are "Cow's Milk Allergy" (9 trials), "Coronary Artery Disease" (4 trials), "Cow Milk Allergy" (3 trials), "Heart Failure" (3 trials) and "Myocardial Infarction" (3 trials). Many other conditions were trialed in "University of Naples Federico II" in a lesser frequency.

Most popular intervention types in "University of Naples Federico II" are "Drug" (41 trials), "Dietary Supplement" (25 trials), "Other" (17 trials), "Device" (13 trials) and "Procedure" (13 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "placebo" (4 trials), "gemcitabine" (3 trials), "Cangrelor" (2 trials) and "Endoscopic Endonasal Pituitary Surgery" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Naples Federico II" are 106 trials for "All" genders, 7 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "University of Naples Federico II". undefined are not yet recruiting, 15 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 68 completed trials in University of Naples Federico II, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in University of Naples Federico II, 2 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 30 trials that are defined as “Not Applicable".